COLD ISCHEMIA IN THE ABSENCE OF ALLOREACTIVITY INDUCES CHRONIC TRANSPLANT NEPHROPATHY THROUGH A PROCESS MEDIATED BY THE PLATELET-ACTIVATING FACTOR1
- 1 December 2000
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 70 (11) , 1624-1631
- https://doi.org/10.1097/00007890-200012150-00015
Abstract
Ischemia-reperfusion injury is considered a risk factor for the development of chronic transplant nephropathy (CTN) although the mechanisms that mediate its effects have not been completely established. We have previously shown that treatment with a platelet-activating factor (PAF) receptor antagonist (UR12670) protected kidneys from the progression to chronic nephropathy induced by warm ischemia. Here we examine the contribution of cold ischemia to the development of late functional and structural kidney changes in rats subjected to syngeneic renal transplantation and the role of PAF in this chronic nephropathy. Lewis rats were used as kidney donors and recipients, which were transplanted either immediately or after a cold ischemia period of 5 hr. Contralateral nephrectomy was performed on the seventh day after transplantation. Cyclosporine was administered for 15 days after transplantation. Groups were as follows: Sy, immediate transplantation; SyI, transplantation after 5 hr of cold ischemia; SyIUr, transplantation after 5 hr of cold ischemia plus UR12670 from the transplantation day to the end of the study, at 24 weeks. Serum creatinine, creatinine clearance, and proteinuria were determined every 4 weeks. UrinaryKeywords
This publication has 28 references indexed in Scilit:
- Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized ratsKidney International, 1999
- LATE GRAFT DYSFUNCTION AFTER PROLONGED COLD ISCHEMIA OF THE DONOR KIDNEYTransplantation, 1999
- Expression of the PAF Receptor in Human Monocyte–Derived Macrophages Is Downregulated by Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Guanine Nucleotide Regulatory Proteins, Gq and Gi1/2, Mediate Platelet‐Activating Factor‐Stimulated Phosphoinositide Metabolism in Immortalized Hippocampal CellsJournal of Neurochemistry, 1996
- Design, Synthesis, and Structure−Activity Relationship Studies of Novel 1-[(1-Acyl-4-piperidyl)methyl]-1H-2-methylimidazo[4,5-c]pyridine Derivatives as Potent, Orally Active Platelet−Activating Factor AntagonistsJournal of Medicinal Chemistry, 1996
- Chronic renal transplant lossKidney International, 1995
- Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia modelTransplant International, 1993
- CHRONIC REJECTION OF RAT RENAL ALLOGRAFTSTransplantation, 1992
- INCREASED MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN EXPRESSION IN UNILATERAL ISCHEMIC ACUTE TUBULAR NECROSIS IN THE MOUSETransplantation, 1990
- CYCLOSPORINE AND THE ISCHEMIC RAT KIDNEYTransplantation, 1986